Published on 31 August 2026
Description:
This month's mag takes the relentless tittle-tattle from 'influencers' about GLP-1 before scrutinizing, deconstructing and refining it in a way only we can! In that spirit, we ask: where have all the risk takers gone, why isn't communication at the top table, and how do we make the most of data? As we bid farewell to a scorching summer, there's still time to focus on the future of clinical trials and how pharma can navigate an exponentially changing NHS.
Categories:
PharmaTimesPreview:
27 articles from this collection:
September 2026
2 Ad
3 From the editor
4-5 Contents
6 NEWS: Treatments
7 NEWS: Collaborations
8 NEWS: Clinical Trials
9 NEWS: Conditions
10-12
13 - Connected Trials
14-15
16-17
18-19
20-21
22-23
24 - Future Proof
25 - Cell Story
26-27
28 - NHS Relations
29 - MADWorld Ad
30-32
33 - Liver
34-35
36-37
38 - AI
39 - EHP Awards
40 - Pharmatimes Awards
PharmaTimes
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.